What were the main outcomes of Cardinal Health's 2023 Annual Meeting of Shareholders?

The main outcomes include the election of all 11 director nominees, ratification of Ernst & Young LLP as the independent auditor for FY2024, approval of executive compensation on an advisory basis (say-on-pay), and a vote in favor of annual say-on-pay votes. However, two shareholder proposals regarding executive stock retention and termination pay ratification were not approved.

Did the shareholders approve the executive compensation package?

Yes, shareholders approved the executive compensation on a non-binding advisory basis (say-on-pay) with approximately 182.7 million 'For' votes versus 16.9 million 'Against' votes. They also voted in favor of holding these advisory votes annually.

Which shareholder proposals were rejected?

Two shareholder proposals were not approved by the shareholders. The first was a proposal to adopt a policy requiring executives to retain significant stock. The second was a proposal to adopt a policy requiring shareholder ratification of excessive termination pay.

What does the high number of 'Broker Non-Votes' indicate?

Broker non-votes occur when a broker holds shares on behalf of a client (in 'street name') but does not receive voting instructions from the client for a particular proposal. The high number of broker non-votes suggests that a substantial portion of shares held by beneficial owners did not have their votes cast on certain matters, particularly the shareholder proposals and some director elections.

CAH 8-K: Shareholder Matters

Summary

Cardinal Health, Inc. (CAH) filed an 8-K on November 16, 2023, reporting the results of its Annual Meeting of Shareholders held on November 15, 2023. The primary focus of this filing is the outcome of six proposals voted upon by shareholders. Investors will be interested to note that all director nominees were elected, and the company's appointment of Ernst & Young LLP as its independent auditor for fiscal year 2024 was ratified with overwhelming support. Additionally, shareholders approved the executive compensation on an advisory basis (say-on-pay) and supported holding such votes annually. However, two shareholder proposals did not pass: one seeking a policy for executive stock retention and another for shareholder ratification of excessive termination pay. These outcomes suggest that while shareholders are generally aligned with the board's composition and compensation practices, they rejected specific proposals aimed at increasing executive accountability through stock retention and termination pay oversight. The high number of broker non-votes on most proposals indicates that a significant portion of shares held in 'street name' did not have voting instructions from the beneficial owners for these particular items.

Key Highlights

1All 11 director nominees were elected by shareholders, indicating continued confidence in the board's composition.
2Ernst & Young LLP was ratified as the independent auditor for fiscal year 2024 with strong shareholder approval.
3Shareholders approved the executive compensation on a non-binding advisory basis (say-on-pay) with a majority vote in favor.
4A majority of shareholders voted in favor of holding annual advisory votes on executive compensation ('say-on-frequency').
5A shareholder proposal to adopt a policy requiring executives to retain significant stock was not approved.
6A shareholder proposal to adopt a policy requiring shareholder ratification of excessive termination pay was not approved.
7A significant number of broker non-votes were recorded for most proposals, particularly concerning director elections and shareholder proposals.

CARDINAL HEALTH INC 8-K Report, Shareholder Vote Results (Nov 16, 2023)

Summary

Key Highlights

Frequently Asked Questions